The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Spanish active pharmaceutical ingredient (API) maker Interquim, S.A. for several good manufacturing practices ...
The FDA has suggested an Indian API maker hire a consultant that understands FDA regulations after finding the company didn’t have a grasp of some basic requirements, including how to make sure the ...
The FDA found that a Canadian API maker was not testing the products it shipped to the U.S. (FDA) An FDA inspector didn’t have to spend long to discover that a Canadian API maker was failing to meet ...
The US Food and Drug Administration (FDA) on Monday released a warning letter sent to active pharmaceutical ingredient (API) maker Qinhuangdao Zizhu Pharmaceutical for data integrity issues uncovered ...
Mumbai, Oct 12 () Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday. Mumbai, Oct 12 ( ...
In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results